Today in healthcare, Vetster introduces a digital pet pharmacy, three-quarters of young consumers want healthcare payment plans and Warby Parker eyes direct-to-consumer (D2C) eye care.
Report: Three-Quarters Of Younger Consumers Want Healthcare Payment Plans
“Generation HealthTech: How Digital Tools Amplify Millennial Patient Loyalty,” a PYMNTS and Rectangle Health collaboration, finds millennials are more willing than older generations to switch providers to find the right mix of care and customer experience options, as well as being likelier to avoid regular engagement with a primary care physician.
Recent healthcare industry insights find that millennial consumers’ health begins to decline at age 27. Forty-four percent of older millennials are already struggling with chronic ailments, meaning medical care services must discover the digital healthcare management options that matter most to this generation and learn how to leverage them to drive millennial engagement.
Vetster Unveils Digital Pet Pharmacy
Veterinary telehealth and pet care company Vetster on Tuesday (Aug. 24) announced the creation of VetsterRx Online Pharmacy, an online pet pharmacy with a veterinary telehealth platform that includes pet medication delivery service for U.S. customers, available online and through the mobile app.
Pet owners can book virtual vet appointments on Vetster.com or by downloading the mobile app in the Apple App Store or Google Play Store.
Warby Parker’s IPO Filing: Red Ink, And A Vision For D2C Eye Care
Warby Parker noted in its SEC filing on Tuesday (Aug. 24) that 8 percent of glasses are sold online across an industry worth $21 billion in the U.S. and $140 billion globally. The company noted that, its active customer base stands at more than 2 million individuals. The model is omnichannel — accessible via app, online or at 145 retail locations.
The bulk of sales (95 percent) comes from the sale of glasses, 2 percent comes from contacts, 2 percent comes from accessories and 1 percent from eye exams. The firm notes that D2C telehealth, which would include vision, is slated to surpass $16 billion by 2025. The company estimated that it has sold glasses and contacts to less than 2 percent of adults in the U.S. who use vision correction.